ACCC overstates chemist merger risks claims Barrenjoey

MELBOURNE: The competition regulator entirely ignored a major wholesaler when it warned that ... read more
Telix pulls $300m Nasdaq IPO as investors demand deep discount

MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 ... read more